» Articles » PMID: 17332281

Epigenetic Silencing of the Candidate Tumor Suppressor Gene Per1 in Non-small Cell Lung Cancer

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2007 Mar 3
PMID 17332281
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Epigenetic events are a critical factor contributing to cancer development. The purpose of this study was to identify tumor suppressor genes silenced by DNA methylation and histone deacetylation in non-small cell lung cancer (NSCLC).

Experimental Design: We used microarray analysis to screen for tumor suppressor genes.

Results: We identified Per1, a core circadian gene, as a candidate tumor suppressor in lung cancer. Although Per1 levels were high in normal lung, its expression was low in a large panel of NSCLC patient samples and cell lines. Forced expression of Per1 in NSCLC cell lines led to significant growth reduction and loss of clonogenic survival. Recent studies showed that epigenetic regulation, particularly histone H3 acetylation, is essential for circadian function. Using bisulfite sequencing and chromatin immunoprecipitation, we found that DNA hypermethylation and histone H3 acetylation are potential mechanisms for silencing Per1 expression NSCLC.

Conclusions: These results support the hypothesis that disruption of circadian rhythms plays an important role in lung tumorigenesis. Moreover, our findings suggest a novel link between circadian epigenetic regulation and cancer development.

Citing Articles

A prognostic model of lung adenocarcinoma constructed based on circadian rhythm genes and its potential clinical significance.

Fu C, Sun L, Feng C, Zhou T, Bi Y Front Oncol. 2025; 15:1464578.

PMID: 40040723 PMC: 11876053. DOI: 10.3389/fonc.2025.1464578.


Impact of Circadian Clock Gene Overexpression on Rumen Epithelial Cell Dynamics and VFA Transport Protein Expression.

Ali R, Zhen Y, Zanna X, Lin J, Zhang C, Ma J Int J Mol Sci. 2024; 25(22).

PMID: 39596493 PMC: 11594904. DOI: 10.3390/ijms252212428.


Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life.

Kisamore C, Kisamore C, Walker 2nd W Cancer Med. 2024; 13(20):e70353.

PMID: 39463009 PMC: 11513439. DOI: 10.1002/cam4.70353.


The role of circadian clocks in cancer: Mechanisms and clinical implications.

Liu H, Liu Y, Hai R, Liao W, Luo X Genes Dis. 2023; 10(4):1279-1290.

PMID: 37397565 PMC: 10310980. DOI: 10.1016/j.gendis.2022.05.014.


Circadian clock-based therapeutics in chronic pulmonary diseases.

Giri A, Rahman I, Sundar I Trends Pharmacol Sci. 2022; 43(12):1014-1029.

PMID: 36302705 PMC: 9756397. DOI: 10.1016/j.tips.2022.09.004.